Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model
Yiftah Barsheshet, Yoram Palti(Novocure (United States))
Cited by 43
Related Papers
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
|Cancer Immunology Immunotherapy|2020|163